A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples